Jeffrey Rosenfeld
Fortuna: 20 679 $ al 31/05/2026
Fortuna: 20 679 $ al 31/05/2026
Jeffrey Rosenfeld is currently the Chairman at Clinuvel Pharmaceuticals Ltd. He previously worked as the Director-Neurosurgery at Alfred Health and as the Head-Surgery & Professor at Monash University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2025 | 3.148 ( 0,01 % ) | 20 679 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Presidente | 01/01/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Alfred Health
Alfred Health Hospital/Nursing ManagementHealth Services Operates as a hospital | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Clinuvel Pharmaceuticals Ltd.
Clinuvel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for patients with genetic, metabolic and life-threatening disorders | Health Technology |
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alfred Health
Alfred Health Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.